These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3207617)

  • 1. Hand warming as a treatment for Raynaud's phenomenon in systemic sclerosis.
    Goodfield MJ; Rowell NR
    Br J Dermatol; 1988 Nov; 119(5):643-6. PubMed ID: 3207617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of simple warming procedures on finger blood flow in systemic sclerosis.
    Goodfield MJ; Hume A; Rowell NR
    Br J Dermatol; 1988 May; 118(5):661-8. PubMed ID: 2969257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynaud's phenomenon in patients with systemic sclerosis: a double blind randomised study.
    Rademaker M; Cooke ED; Almond NE; Beacham JA; Smith RE; Mant TG; Kirby JD
    BMJ; 1989 Mar; 298(6673):561-4. PubMed ID: 2467711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for an abnormal peripherally mediated vascular response to temperature in Raynaud's phenomenon.
    Walmsley D; Goodfield MJ
    Br J Rheumatol; 1990 Jun; 29(3):181-4. PubMed ID: 2357499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological classification of Raynaud's phenomenon.
    Nilsen KH
    Br J Dermatol; 1980 Jan; 102(1):1-5. PubMed ID: 7378276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood viscosity, Raynaud's phenomenon and the effect of fibrinolytic enhancement.
    Ayres ML; Jarrett PE; Browse NL
    Br J Surg; 1981 Jan; 68(1):51-4. PubMed ID: 7459607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the functioning of arteriovenous anastomoses in secondary Raynaud's phenomenon and control subjects in response to local hand warming.
    Toms SL; Cooke ED
    Int Angiol; 1995 Mar; 14(1):74-9. PubMed ID: 7658109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of severe Raynaud's syndrome by injection of autologous blood pretreated by heating, ozonation and exposure to ultraviolet light (H-O-U) therapy.
    Cooke ED; Pockley AG; Tucker AT; Kirby JD; Bolton AE
    Int Angiol; 1997 Dec; 16(4):250-4. PubMed ID: 9543222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of cold challenge responses in primary Raynaud's phenomenon and Raynaud's phenomenon associated with systemic sclerosis.
    O'Reilly D; Taylor L; el-Hadidy K; Jayson MI
    Ann Rheum Dis; 1992 Nov; 51(11):1193-6. PubMed ID: 1466594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digital blood flow response to body warming, cooling, and rewarming in patients with Raynaud's phenomenon.
    Lau CS; Khan F; Brown R; McCallum P; Belch JJ
    Angiology; 1995 Jan; 46(1):1-10. PubMed ID: 7818151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laser Doppler-recorded venoarteriolar reflex in Raynaud's phenomenon.
    Stoyneva Z
    Auton Neurosci; 2004 Nov; 116(1-2):62-8. PubMed ID: 15556839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal amplitude and kinetics of digital postocclusive reactive hyperemia in systemic sclerosis.
    Gaillard-Bigot F; Roustit M; Blaise S; Gabin M; Cracowski C; Seinturier C; Imbert B; Carpentier P; Cracowski JL
    Microvasc Res; 2014 Jul; 94():90-5. PubMed ID: 24990822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral N-acetylcysteine in the treatment of Raynaud's phenomenon secondary to systemic sclerosis: a randomized, double-blind, placebo-controlled clinical trial].
    Correa MJ; Mariz HA; Andrade LE; Kayser C
    Rev Bras Reumatol; 2014; 54(6):452-8. PubMed ID: 25458027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of local temperature versus sympathetic tone on digital perfusion in Raynaud's phenomenon.
    Engelhart M; Seibold JR
    Angiology; 1990 Sep; 41(9 Pt 1):715-23. PubMed ID: 2221472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postocclusive reactive hyperemia in hand-arm vibration syndrome.
    Stoyneva Z
    Int J Occup Med Environ Health; 2016; 29(4):659-66. PubMed ID: 27443761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raynaud's phenomenon.
    Wigley FM; Flavahan NA
    Rheum Dis Clin North Am; 1996 Nov; 22(4):765-81. PubMed ID: 8923595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of infrared thermography as an endpoint in therapeutic trials of Raynaud's phenomenon and systemic sclerosis.
    Pauling JD; Shipley JA; Harris ND; McHugh NJ
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S103-15. PubMed ID: 22691218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.
    Merkel PA; Herlyn K; Martin RW; Anderson JJ; Mayes MD; Bell P; Korn JH; Simms RW; Csuka ME; Medsger TA; Rothfield NF; Ellman MH; Collier DH; Weinstein A; Furst DE; Jiménez SA; White B; Seibold JR; Wigley FM;
    Arthritis Rheum; 2002 Sep; 46(9):2410-20. PubMed ID: 12355489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis.
    Watson HR; Robb R; Belcher G; Belch JJ
    J Rheumatol; 1999 Aug; 26(8):1734-7. PubMed ID: 10451070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.
    Motegi S; Yamada K; Toki S; Uchiyama A; Kubota Y; Nakamura T; Ishikawa O
    J Dermatol; 2016 Jan; 43(1):56-62. PubMed ID: 26173902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.